ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
ResMed (RMD) Tops Q3 EPS by 25c, Revenues Beat
April 30, 2020 4:44 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $1.29, $0.25 better than the analyst estimate of $1.04. Revenue for the quarter came in at $769.5 million versus the consensus estimate of $722.52 million.
Third Quarter 2020 Highlights
Year-over-year revenue grows 16%, non-GAAP operating profit up 31%Balanced growth across product portfolio, software solutions, and global marketsFocused on combating COVID-19 pandemic through increased ventilator production and ongoing partnership and support of key global stakeholdersAll comparisons are to the prior-year period
Revenue increased 16% to $769.5 million; up 17% on a constant currency basisGAAP... More